"Oviva hopes to pull off a feat that seems almost unimaginable: giving women a drug that will allow them to choose when—and whether—they go through menopause. At a time when politicians are eroding women’s hard-won reproductive choices, Oviva’s founders want to give them even more control. 'I see it very much akin to how the contraceptive pill really changed the game for women in the ’70s,' Daisy Robinton, PhD says." We are thrilled and humbled to be featured in this insightful story from Bloomberg via Kristen V. Brown detailing the latest innovations in women's health and the effort to forestall or eradicate menopause -- and in doing so possibly preserving fertility and female healthspan. Our co-founders David Pepin and Daisy Robinton, PhD were interviewed for the piece, along with several other luminaries from the field. Check it out below! https://lnkd.in/gec9jXuD #womenshealth #innovation #longevity #healthspan #futureofhealth #health #medicine #menopause #fertility Oviva Therapeutics Jennifer Garrison Rachel Rimsky Rubin Lorna Fiedler, PhD Cambrian Bio James Peyer, PhD
Amazing company! I first saw them profiled in the Boston Globe… this will revolutionize women’s health♥️
🙌🙌🙌
Amazing piece capturing the importance of the incredible work being done by this Oviva Therapeutics team 👏